SCHEMBL1966035

SCHEMBL1966035

Nc1ccc(C(=O)Nc2ccc(Cl)cn2)cc1N

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.65
NPC1 O15118 9/20 0.65
KMT2A Q03164 5/20 0.65
SMN1; SMN2 Q16637 8/20 0.63
TP53 P04637 4/20 0.63
TSHR P16473 4/20 0.63
NFKB1 P19838 3/20 0.63
NFKB2 Q00653 3/20 0.63
RELA Q04206 3/20 0.63
ALDH1A1 P00352 2/20 0.61
PKM P14618 1/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2D6 P10635 2/20 0.61
CYP2C19 P33261 2/20 0.61
POLB P06746 1/20 0.61
CYP3A4 P08684 1/20 0.61
ALOX15 P16050 1/20 0.61
MEN1 O00255 3/20 0.59
MAPT P10636 1/20 0.58
BRD4 O60885 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1971692 0.83 NPC1 (0.69) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL27640883 0.82 SORT1 (0.62) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL1998921 0.81 F10 (0.60) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL28339146 0.80 KMT2A (0.56) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL4857006 0.80 RAB9A (0.56) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL12501925 0.80 RAB9A (0.72) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL16318472 0.80 DEGS1 (0.56) RAB9ANPC1KMT2AMEN1F10
SCHEMBL3165548 0.79 RAB9A (0.77) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL3151641 0.79 SORT1 (0.61) RAB9ANPC1KMT2ASMN1; SMN2TP53
SCHEMBL3157401 0.79 KMT2A (0.57) RAB9ANPC1KMT2ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed